This page lays out the fields published on Portal BASE and says when a field is unavailable. It is not an assessment of the contract's merit, legality or impact.

Record 4941456

PUBLISHED SUBJECT

AZACITIDINA 100 MG PÓ SUSP INJ BLEOMICINA,15 U PÓ SOL INJ FR IM IV BORTEZOMIB 3.5 MG PÓ SOL INJ FR PEMETREXED 500MG,PÓ CONC SOL INJ FR IV Pemetrexedo 100 mg Pó conc sol inj Fr IV

Parties involved

Place of performance
Portugal, Setúbal, Setúbal
NUTS region
Not stated

WHO BID

Awardee and competitors

Companies that IMPIC lists as the awardee and as competitors in this procedure.

Awardee
JANSSEN CILAG FARMACEUTICA, LDA · Tax ID 500189412
Awardee
CELGENE SOCIEDADE UNIPESSOAL LDA · Tax ID 507791690
Awardee
MEDAC · Tax ID 980369959

Values and timeline

Contract price
€49,701.70
Procedure base price
€49,701.70
Total effective price
Not reported on Portal BASE
Publication date
12 November 2018
Award date
23 October 2018
Signing date
23 October 2018
Performance period
15 days

The contract price is the value agreed in the contract, not the amount paid.

Procedure and framework

Contract type
Aquisição de bens móveis
Award criterion
Melhor relação qualidade – preço
CPV code
33600000-6 - Produtos farmacêuticos
Legal basis
Artigo 20.º, n.º 1, alínea d) do Código dos Contratos Públicos
Regime
Código dos Contratos Públicos ( DL 111-B/2017 )
Framework agreement
Not stated
Centralised procedure
No
Environmental criterion
No
Notice
Not stated
Procedure identifier
3668402

Compare with other contracts

Search the same body, supplier, place or type of service to understand the context of the published index.

← Back to contracts